Vioxx Plaintiffs Say Merck Not Prejudiced, Dismissal Unwarranted
October 11, 2006
DOCUMENTS
- Motion & Memorandum
- Opposition
NEW ORLEANS - Several plaintiffs in the federal Vioxx MDL have opposed Merck & Co. Inc.'s motion to dismiss their claims, stating that they are not in violation of any pretrial discovery requirements because they do not allege cardiovascular injuries. In Re: Vioxx Products Liability Litigation, MDL No. 1657 (E.D. La.).
Merck filed a motion and memorandum asking the U.S. District Court for the Eastern District of Louisiana to order 10 plaintiffs to appear and show cause why their claims should not be dismissed with prejudice for failure to timely provide any response to the Plaintiff Profile Form as required …
UPCOMING CONFERENCES

HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
April 08, 2025 - Long Beach, CA
The Westin Long Beach

HarrisMartin's Data Breach Litigation Conference
March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel